| scholarly article | Q13442814 |
| P2093 | author name string | Philippe Dartevelle | |
| François Stéphan | |||
| Julien Camous | |||
| Sylvie Doubine | |||
| Virginie Louvain-Quintard | |||
| Thibaut Decrombecque | |||
| P2860 | cites work | Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines | Q22255576 |
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery | Q33334149 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| The relationship between the antiphospholipid syndrome and heparin-induced thrombocytopenia | Q33378338 | ||
| False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus | Q33383739 | ||
| Clinical and biologic features of patients suspected or confirmed to have heparin-induced thrombocytopenia in a cardiothoracic surgical ICU. | Q33400183 | ||
| Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations | Q33487732 | ||
| Differential diagnosis of central nervous system manifestations of the antiphospholipid antibody syndrome | Q34021244 | ||
| Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients | Q34435380 | ||
| The importance of diagnosing and managing ICU delirium | Q36910246 | ||
| The antiphospholipid syndrome and heart valve surgery | Q37033025 | ||
| Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study | Q40533021 | ||
| Risk factors for chronic thromboembolic pulmonary hypertension. | Q44236882 | ||
| Surgical treatment of chronic thromboembolic pulmonary hypertension. | Q44467757 | ||
| Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. | Q48839463 | ||
| IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. | Q50933721 | ||
| Predictors of outcome in chronic thromboembolic pulmonary hypertension. | Q51028260 | ||
| Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients | Q56907610 | ||
| P433 | issue | 1 | |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 116-120 | |
| P577 | publication date | 2013-12-19 | |
| P1433 | published in | European Journal of Cardio-Thoracic Surgery | Q2178577 |
| P1476 | title | Outcomes of patients with antiphospholipid syndrome after pulmonary endarterectomy | |
| P478 | volume | 46 |
| Q57059278 | Curative resolution of chronic thromboembolic pulmonary hypertension with pulmonary thromboendarterectomy in primary antiphospholipid syndrome: A case report |
| Q33419915 | Perioperative anticoagulation management in antiphospholipid syndrome |
| Q38325716 | Pulmonary hypertension in antiphospholipid syndrome |
| Q90369086 | Ramelteon for Prevention of Postoperative Delirium: A Randomized Controlled Trial in Patients Undergoing Elective Pulmonary Thromboendarterectomy |
| Q50101713 | Reversible Parkinsonism and Multiple Cerebral Infarctions after Pulmonary Endarterectomy in a Patient with Antiphospholipid Syndrome |
| Q50218014 | The effective systematic heparin pre-treatment on thrombus formation on pulmonary artery catheter tips during pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a randomized, double-blind study |
Search more.